Pradaxa Internal Bleeding Class Action Lawsuit Investigation

Pradaxa (dabigatran) was approved by the FDA in 2010 and was quickly found to have possibly caused a multitude of serious, and possibly life threatening injuries. The Pradaxa Internal Bleeding Class Action Lawsuit Investigation is actively researching claims from consumers that were possibly injured by Pradaxa.

 

Pradaxa users have complained of experiencing problems like severe and uncontrollable intestinal bleeding, gastrointestinal bleeding, brain hemorrhage, kidney bleeding, internal bleeding, heart attack and even death from Pradaxa.  If you have experienced severe problems which may be because of Pradaxa the attorneys in charge of the Pradaxa Internal Bleeding Class Action Lawsuit Investigation want to know.

 

Submit your information to the attorneys at Top Class Actions now to see if you qualify for free. They don't get paid unless you do. Submit your information below.

 

Pradaxa Lawsuit

First Name (*)

Invalid Input - Please Enter Your First Name

Last Name (*)

Invalid Input

Street Address (*)

Invalid Input - Please Enter Your Street Address

City (*)

Invalid Input - Please Enter Your City

Select Your State (*)
ALAKAZARCACOCTDEDCFLGAHIIDILINIAKSKYLAMEMDMAMIMNMSMOMTNENVNHNJNMNYNCNDOHOKORPARISCSDTNTXUTVTVAWAWVWIWYNot Listed
Invalid Input - Please Select Your State

Zip Code (*)

Invalid Input - Please enter your Zip Code

Home Phone Number (*)

Invalid Input - Please Enter Your Home Phone Number

Work or Mobile Phone Number (*)

Invalid Input - Please enter your work or mobile phone number

Email Address (*)

Invalid Input - Please Enter Your Email Address

Have you or a loved one been diagnosed with internal bleeding problems and used Pradaxa? (*)
YesNo
Invalid Input - Please Select Yes or No as to whether you, your child or a loved one have been diagnosed with internal bleeding problems and used Pradaxa?

Please check the injuries suffered:
Internal Bleeding
Kidney Bleeding
Gastrointestinal Bleeding
Heart Attack
Brain Hemorrhage
Death

Invalid Input

Please enter any additional details you'd like the staff reviewing your submission to know.

Invalid Input

I understand and agree that submitting this form does not create an attorney-client relationship and that the information I submit is not confidential or privileged and may be shared. (*)
Yes
Invalid Input - Please read and understand the terms before checking the box.

Text Verification

Invalid Input - Please enter the text shown so we know you're a real person.

Click on "Submit" to send us your information

 

Pradaxa (dabigatran) is a relatively new anticoagulant drug manufactured by Boehringer Ingelheim Pharmaceuticals. Pradaxa is in a class of drugs called Direct Thrombin Inhibitors, otherwise known as blood thinners or anticoagulants. As we mentioned Pradaxa was approved by the FDA in October of 2010 as an anticoagulant drug that was superior to the prescription drug Coumadin (warfarin) because it allegedly required less monitoring of the patient and no, or very little, change of diet. However, users of the drug Coumadin (warfarin) who experienced abdominal bleeding could counteract those side effects by flushing their body with Vitamin K which allows their blood to clot normally once again, stopping internal bleeding. There is no similar solution available to address people who experience internal bleeding while taking Pradaxa. In just the first three months on the market, the FDA received 307 reports of Pradaxa problems involving internal bleeding, gastrointestinal bleeding, and other serious health complications. Within the first year, there were more than 260 reported deaths allegedly from Pradaxa due to internal bleeding, gastrointestinal bleeding, hemorrhage and stroke. The Pradaxa side effect lawsuits allege that the problem with Pradaxa is that once a hemorrhage or internal bleed starts there is no way to stop the bleed until the body is flushed of Pradaxa by dialysis. This may take hours and result in multiple blood transfusions for the patient or their death.

 

In December, 2011, the FDA (U.S. Food and Drug Administration) issued a warning notifying users of Pradaxa of the serious risk of uncontrollable internal bleeding which may be attributed to the use of Pradaxa. A Pradaxa Class Action Lawsuit has been filed due to the alleged serious side effects of Pradaxa and the alleged misleading of consumers regarding the safety of Pradaxa. Pradaxa lawsuits allege that Boehringer Ingelheim knew of the severe side effects of Pradaxa but didn't notify patients, or their prescribing physicians, of the risk of internal bleeding, hemorrhage, and death while taking Pradaxa.

 

It's known that all blood thinning and anticoagulant drugs cause bleeding, however Pradaxa allegedly has an increased risk of excessive bleeding which is a very dangerous side effect. Symptoms of internal bleeding or hemorrhage include bruising without any known cause, frequent nose bleeds, bleeding from the gums, discolored urine, red or black stools (poop,) coughing up blood, and possibly vomiting blood.

 

A Pradaxa Class Action Lawsuit may be filed when many people have experienced the same, or a very similar injury. This could be financial damages, medical expenses, time away from work due to injury or even time away from work while caring for an injured or sick loved one. Sometimes a class action lawsuit may not be the best strategy for someone injured by Pradaxa. In that case, an attorney representing you personally may be the best course of action. If you are represented individually because you or a loved one has been injured by Pradaxa you may have a much better chance of being compensated for your injuries, medical treatment and pain and suffering due to Pradaxa side effects. Pradaxa attorneys are also available to families who lost a loved one allegedly due to a Pradaxa side effect. If your loved one died while taking Pradaxa you may be able to file a wrongful death lawsuit against Boehringer Ingelheim.

E-mail any problems with this form to  This email address is being protected from spambots. You need JavaScript enabled to view it.

Top Class Actions is a Proud Member of the American Bar Association

ATTORNEY ADVERTISING